Broxoflem 6mg/ mL Syrup (Oral Drops) Philippines - English - FDA (Food And Drug Administration)

broxoflem 6mg/ ml syrup (oral drops)

vonnace pharmaceuticals corporation - ambroxol hydrochloride - syrup (oral drops) - 6mg/ ml

Gelminthic 125mg/ 5mL Suspension Philippines - English - FDA (Food And Drug Administration)

gelminthic 125mg/ 5ml suspension

vonnace pharmaceuticals corporation - pyrantel (as embonate) - suspension - 125mg/ 5ml

Floxagen 400mg Tablet Philippines - English - FDA (Food And Drug Administration)

floxagen 400mg tablet

vonnace pharmaceuticals corporation - ofloxacin - tablet - 400mg

Gentacid 225 mg/200 mg per 5 mL Suspension Philippines - English - FDA (Food And Drug Administration)

gentacid 225 mg/200 mg per 5 ml suspension

vonnace pharmaceutical corporation - aluminum hydroxide , magnesium hydroxide - suspension - 225 mg/200 mg per 5 ml

Broxoflem 30 mg/5 mL Syrup Philippines - English - FDA (Food And Drug Administration)

broxoflem 30 mg/5 ml syrup

vonnace pharmaceuticals corp. - ambroxol hydrochloride - syrup - 30 mg/5 ml

Cytragen 100 mg Capsule Philippines - English - FDA (Food And Drug Administration)

cytragen 100 mg capsule

vonnace pharmaceuticals corp. - doxycycline (as hydrochloride) - capsule - 100 mg

Floxagen 200 mg Tablet Philippines - English - FDA (Food And Drug Administration)

floxagen 200 mg tablet

vonnace pharmaceutical corporation - ofloxacin - tablet - 200 mg

Prizogen 800mg + 160mg Tablet Philippines - English - FDA (Food And Drug Administration)

prizogen 800mg + 160mg tablet

vonnace pharma'l corp - trimethoprim , sulfamethoxazole - tablet - 800mg + 160mg

MONACE fosinopril sodium 20 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

monace fosinopril sodium 20 mg tablet blister pack

alphapharm pty ltd - fosinopril sodium, quantity: 20 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; hyprolose; crospovidone; glyceryl behenate - monace is indicated for the treatment of mild to moderate hypertension. monace is effective alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of monace and diuretics used concomitantly are approximately additive. data have not been provided to support the use of monace in severe or renovascular hypertension. heart failure: monace is indicated for the management of heart failure when added to conventional therapy, including diuretics.

MONACE fosinopril sodium 10 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

monace fosinopril sodium 10 mg tablet blister pack

alphapharm pty ltd - fosinopril sodium, quantity: 10 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; hyprolose; crospovidone; glyceryl behenate - monace is indicated for the treatment of mild to moderate hypertension. monace is effective alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of monace and diuretics used concomitantly are approximately additive. data have not been provided to support the use of monace in severe or renovascular hypertension. heart failure: monace is indicated for the management of heart failure when added to conventional therapy, including diuretics.